Regression of High-Risk Plaque with Lifestyle Changes

Diet and lifestyle intervention in addition to optimal medical therapy can slow down plaque building and even reduce plaque volume compared against optimal medical treatment (OTM) alone.

Regresión de placas de alto riesgo con cambios del estilo vida

Diet and lifestyle intervention are amongst the most important strategies to manage coronary artery disease. However, its direct impact on atherosclerosis remains unclear. 

Atherosclerosis plaque building is associated with the risk of rupture with cardiovascular consequences regardless stenosis degree. 

The present study recently published in J Am Coll Cardiol Img included 92 patients with non-obstructive coronary lesions by CT scan. 

Patients were randomized 1:1 to an intervention group (systematic followup with nutritionist and lifestyle changes + OTM) vs. A control group (OTM alone). 


Read also: ACC 2019 | The New ACC/AHA Guidelines on Primary Prevention Focus on Life Style, Diet and Socioeconomic Factors.


In all patients, CT was repeated after 66.9 ± 13.7 weeks. Primary end point was atheroma volume change and plaque composition. 

Coronary plaque components were classified based on Hounsfield units into dense calcium (>351 units), fibrous plaque (151 to 350 units) and fibrofatty plaque combined with necrotic core (-30 to 150 units).

Atheroma volume increased in the control branch (changed from 1.1 ± 3.4%; p=0.033) while remaining stable in the intervention group (change from 1% ± 4.2%. p=0.127).


Read also: The Crucial Significance of Lifestyle Changes.


A significant reduction in soft plaque was seen in both branches, though it was higher in the intervention group, where it reached mean 51.3 mm3.

Conclusion

Diet and lifestyle intervention together with OMT can slow down atherosclerosis progression and reduce non-calcified plaque volume compared against OMT alone. 

Original Title: High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease. A Randomized Study.

Reference: Jan Henzel et al. J Am Coll Cardiol Img 2020, article in press. https://doi.org/10.1016/j.jcmg.2020.10.019.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....